Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -107.99% is 40% above its 5-year average of -181.19%, near the high end of its 5-year range (-840.78%–-22.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 54.96% above its 12-month average of -239.76%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -107.99%.
RETURN ON INVESTED CAPITAL (ROIC)
-107.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-239.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-323.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-181.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-89.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-108.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-109.17%
CURRENT VS TTM AVG
+54.96%
CURRENT VS 3Y AVG
+66.59%
CURRENT VS 5Y AVG
+40.40%
CURRENT VS 10Y AVG
-21.32%
CURRENT VS 15Y AVG
+0.06%
CURRENT VS 20Y AVG
+1.08%
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 664 covered companies
CURRENT VS SECTOR MEDIAN
-223.47%
vs the sector median at left
Enveric Biosciences, Inc.
Market Cap
$6.55M
Return on Invested Capital (ROIC)
-107.99%
TTM Avg
-239.76%
3Y Avg
-323.21%
5Y Avg
-181.19%
Market Cap
$6.90M
Return on Invested Capital (ROIC)
-90.17%
TTM Avg
-79.44%
3Y Avg
-64.42%
5Y Avg
-71.54%
Market Cap
$6.47M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-251.59%
3Y Avg
-2172.61%
5Y Avg
-1769.42%
Market Cap
$6.66M
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-311.64%
3Y Avg
-524.77%
5Y Avg
-524.77%
Market Cap
$6.27M
Return on Invested Capital (ROIC)
-117.93%
TTM Avg
-116.75%
3Y Avg
-95.39%
5Y Avg
-83.55%
Market Cap
$6.16M
Return on Invested Capital (ROIC)
-209.05%
TTM Avg
-147.42%
3Y Avg
-107.09%
5Y Avg
-98.13%
Market Cap
$6.98M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-383.35%
3Y Avg
-220.46%
5Y Avg
-246.83%
Market Cap
$6.01M
Return on Invested Capital (ROIC)
-82.84%
TTM Avg
-84.28%
3Y Avg
-109.54%
5Y Avg
-250.89%
Market Cap
$7.13M
Return on Invested Capital (ROIC)
-219.15%
TTM Avg
-109.13%
3Y Avg
-72.14%
5Y Avg
-33.59%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.55M | -107.99% | -239.76% | -323.21% | -181.19% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.90M | -90.17% | -79.44% | -64.42% | -71.54% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.47M | N/A | -251.59% | -2172.61% | -1769.42% |
| Aclarion, Inc. (ACON)vs › | $6.66M | -57.11% | -311.64% | -524.77% | -524.77% |
| Biomerica, Inc. (BMRA)vs › | $6.27M | -117.93% | -116.75% | -95.39% | -83.55% |
| Femasys Inc. (FEMY)vs › | $6.16M | -209.05% | -147.42% | -107.09% | -98.13% |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.98M | N/A | -383.35% | -220.46% | -246.83% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.01M | -82.84% | -84.28% | -109.54% | -250.89% |
| Co-Diagnostics, Inc. (CODX)vs › | $7.13M | -219.15% | -109.13% | -72.14% | -33.59% |
| enVVeno Medical Corporation (NVNO)vs › | $5.96M | -80.65% | -65.64% | -61.70% | -66.02% |
ROIC
-108.0%
ROE
-108.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -107.99% |
| 2026-03-31 | -162.43% |
| 2025-12-31 | -210.04% |
| 2025-09-30 | -282.23% |
| 2025-06-30 | -436.11% |
| 2025-03-31 | -238.47% |
| 2024-12-31 | -604.74% |
| 2024-09-30 | -223.80% |
| 2024-06-30 | -188.82% |
| 2024-03-31 | -216.99% |
| 2023-12-31 | -840.78% |
| 2023-09-30 | -774.58% |
| 2023-06-30 | -432.34% |
| 2023-03-31 | -175.45% |
| 2022-12-31 | -128.31% |
| 2022-09-30 | -97.18% |
| 2022-06-30 | -96.46% |
| 2022-03-31 | -79.69% |
| 2021-12-31 | -105.31% |
| 2021-09-30 | -22.72% |
| 2021-06-30 | -57.14% |
| 2021-03-31 | -42.85% |
| 2020-12-31 | -164.46% |
| 2020-09-30 | -28.54% |
| 2020-06-30 | -31.74% |
| 2020-03-31 | -36.27% |
| 2019-12-31 | -40.80% |
| 2019-09-30 | -85.63% |
| 2019-06-30 | -37.14% |
| 2019-03-31 | -33.08% |
| 2018-12-31 | -34.79% |
| 2018-09-30 | -0.27% |
| 2018-06-30 | -43.67% |
| 2018-03-31 | -50.57% |
| 2017-12-31 | -44.95% |
| 2017-09-30 | -51.75% |
| 2017-06-30 | -20.99% |
| 2017-03-31 | -13.68% |
| 2016-12-31 | -17.76% |
| 2016-09-30 | -11.21% |
| 2016-06-30 | -21.30% |
| 2016-03-31 | -9.12% |
| 2015-09-30 | 6.13% |
| 2015-06-30 | 5.23% |
| 2014-09-30 | -534.38% |
| 2014-06-30 | -379.06% |
| 2014-03-31 | -125.90% |
| 2011-12-31 | -689.24% |
| 2011-09-30 | -178.67% |
| 2009-09-30 | -809.63% |
| 2009-06-30 | -556.63% |
| 2009-03-31 | -364.26% |
| 2008-12-31 | -312.45% |
| 2008-09-30 | -216.71% |
| 2008-06-30 | -254.74% |
| 2008-03-31 | -3.18% |
| 2007-12-31 | 16.22% |
| 2007-09-30 | 15.98% |
| 2007-06-30 | 28.40% |
| 2007-03-31 | 7.97% |
| 2006-12-31 | -91.55% |
| 2006-09-30 | -109.23% |
| 2006-06-30 | -75.68% |
| 2006-03-31 | -50.16% |
| 2005-12-31 | -12.41% |
| 2005-09-30 | 28.60% |
| 2005-06-30 | 16.40% |
| 2005-03-31 | -2.51% |
| 2004-12-31 | -17.54% |
| 2004-09-30 | -57.46% |
| 2004-06-30 | -55.99% |
| 2004-03-31 | -57.64% |
| 2003-12-31 | -45.44% |
| 2003-09-30 | -35.35% |
| 2003-06-30 | -22.31% |
